Authors: Bos, AME de Vries, EGE Dombernovsky, P Aamdal, S Uges, DRA Schrijvers, D Wanders, J Roelvink, MWJ Hanauske, AR Bortini, S Capriati, A Crea, AEG Vermorken, JB

Citation: Ame. Bos et al., Pharmacokinetics of MEN-10755, a novel anthracycline disaccharide analogue, in two phase I studies in adults with advanced solid tumours, CANC CHEMOT, 48(5), 2001, pp. 361-369

Authors: Middleton, MR Grob, JJ Aaronson, N Fierlbeck, G Tilgen, W Seiter, S Gore, M Aamdal, S Cebon, J Coates, A Dreno, B Henz, M Schadendorf, D Kapp, A Weiss, J Fraass, U Statkevich, P Muller, M Thatcher, N

Citation: Mr. Middleton et al., Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma, J CL ONCOL, 18(1), 2000, pp. 158-166

Authors: Pavlidis, N Aamdal, S Awada, A Calvert, H Fumoleau, P Sorio, R Punt, C Verweij, J van Oosterom, A Morant, R Wanders, J Hanauske, AR

Citation: N. Pavlidis et al., Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (ECSG), CANC CHEMOT, 46(2), 2000, pp. 167-171

Authors: Aamdal, S Lund, B Koier, I Houten, M Wanders, J Verweij, J

Citation: S. Aamdal et al., Phase I trial with weekly EO9, a novel bioreductive alkylating indoloquinone, by the EORTC Early Clinical Study Group (ECSG), CANC CHEMOT, 45(1), 2000, pp. 85-88

Authors: Semb, KA Aamdal, S Bohmann, T Lucas, C Gerard, B

Citation: Ka. Semb et al., Clinical experience of fotemustine, cisplatin and high dose tamoxifen in patients with metastatic malignant melanoma, MELANOMA RE, 8(6), 1998, pp. 565-572